CC
KLRS

Corton Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Corton Capital’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-456
Closed -$41K – 385
2022
Q2 		$41K Buy
+456
New +$41K 0.04% 317